
Standard treatment for heart failure fails to halt disease progression in patients who suffer from a mutation in the LMNA or RBM20 gene (2000 each in the Netherlands). Ironically, the cardiomyopathies caused by these mutations are characterized by an aggressive clinical course and patients die young due to arrhythmias or need a heart transplant due to severe heart failure despite modern evidence-based therapies. Therefore, there is an urgent medical need to develop novel treatment options for these patients. The increasingly unraveled molecular basis of the disease is our lead, which allow us to directly target the cause of the disease and its molecular effectors leading to cardiac dysfunction.
We are looking for a research technician with a background in cellular or molecular biology that want to join the group of Anke Tijsen and Yigal Pinto in the departement of Experimental Cardiology (location AMC) to investigate several approaches to target the molecular cause of these genetic cardiomyopathies.
In both projects we will use hiPSC derived cardiomyocytes with a genetic mutation in the RBM20 or LMNA gene to investigate whether our molecular approaches indeed relieve the characteristics of the disease. In both projects we will use the newest CRISPR-based genome editing approach (prime-editing) in combination with numerous methods to molecularly and functionally phenotype the cardiomyocytes. The first project aims to rewrite certain areas of the genome as possible therapy (DNA) and the second project aims to molecularly interfere with the mutant mRNA.
To allow us to study the disease mechanisms and possible new therapeutic approaches in human cells we make use of cardiomyocytes, which we differentiate from induced pluripotent stem cells (iPSCs).This position will be focused on developing cellular models for studying how a mutation leads to cellular phenotypes and whether therapeutic approaches influence these phenotypes. The Research Technician will culture undifferentiated iPSCs, differentiate them to cardiomyocytes and perform cellular and molecular assays to determine the phenotypes. Techniques that will be used on the cells or the cellular products are (among others): prime-editing in iPSCs, RNA isolations, (allele-specific) qPCRs, western blotting, lentiviral transductions, immunohistochemistry and microscopy.
We are looking for a highly motivated research technician with a background in molecular and/or cell biology.
The ideal candidate has:
The department of Experimental Cardiology of the Amsterdam UMC, location AMC, is a research laboratory consisting of 6 groups with their own group leader/principal investigator. The work in the department ranges from pure genetic studies to molecular studies on newly identified RNA-species to electrophysiological studies and combinations of these aspects. Our department is part of the ‘Hartcentrum’ of the AMC, which means we are connected to the clinical Cardiology department, which stimulates translational research that benefits the patients suffering from these life-threatening cardiac diseases.
The PhD-students will be part of a small highly motivated group within the research group of Yigal Pinto, this small group consists for now of a junior group leader (Anke Tijsen), 1 technician and 1 PhD-student and we have openings for 1 technician and 2 PhD-students. The group is under daily supervision of the junior group leader, but in close contact with the principal investigator. The small group focuses on the mechanisms underlying cardiac diseases and uses the iPSC-derived cardiomyocytes to study these cardiac diseases with an aim to develop new therapeutics.
We are all easy accessible and work together with an open mind and open door (if needed also in the weekends). We are a highly divers team in terms of culture and background and tend to learn from each other on work and non-work related isssues.
During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely.
Start date is preferably as soon as possible.
Do you have questions? For questions on the content you can contact Dr. Anke Tijsen via a.j.tijsen@amsterdamumc.nl.
For more information on the procedure you can contact Tanja Hart, Recruitment Advisor, via 020 444 5635.
A reference check and screening can be part of the procedure. Read here what this entails. If you would join us, we will ask for a VOG (Verklaring Omtrent Gedrag).
Internal candidates will receive preference to external candidates, if equally qualified.
Acquisition regarding this job opening is not appreciated.